Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen

Erin G. Harper, Eric L. Simpson, Rodd H. Takiguchi, Miranda D. Boyd, Stephen E. Kurtz, Antony C. Bakke, Andrew Blauvelt

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds